Cytochrome CYP2E1 phenotyping and genotyping in the evaluation of health risks from exposure to polluted environments
Authors:
- Danièle LucasDLDanièle Lucas
- Roberta FerraraRFRoberta Ferrara
- Eva GonzalesEGEva Gonzales
- Arnulfo AlboresAAArnulfo Albores
- Maurizio MannoMaurizio Manno
- François BerthouFBFrançois Berthou
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Toxicology Letters
- Vol. 124 (1-3) , 71-81
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Detection and characterization of novel polymorphisms in the CYP2E1 genePharmacogenetics, 1998
- Use of Chlorzoxazone as an In Vivo Probe of Cytochrome P450 2E1: Choice of Dose and Phenotypic Trait MeasureThe Journal of Clinical Pharmacology, 1998
- CYP2E1 activity in patients with alcoholic liver diseaseJournal of Hepatology, 1997
- Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humansHepatology, 1997
- Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazoneXenobiotica, 1997
- Human cytochrome from genotype to phenotypePharmacogenetics, 1996
- Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokineticsBiochemical Pharmacology, 1994
- Grapefruit Juice and DrugsClinical Pharmacokinetics, 1994
- Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazoneChemical Research in Toxicology, 1993
- Role of human cytochrome P‐450s in risk assessment and susceptibility to environmentally based diseaseJournal of Toxicology and Environmental Health, 1993